(er)
Need an official quote in your mailbox?
Our automated system will send you a quote for your specific qty along with Discount, timelines and Stock status.
18:1-12:0 Biotin PE
LIPIDS
| CAT No.# | CS-CC-00179 |
| Category | Lipids |
| CAS | 799812-67-2 |
| Stock Status |
AVAILABLE
Do you want a quotation or have a question about '18:1-12:0 Biotin PE' ? We normally respond within 2 hours.Do you want a quotation or have a question about '18:1-12:0 Biotin PE' ? We normally respond within 2 hours.(Available within 3-5 days) Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing. |
| Molecular Weight | 903.2 |
| Molecular Formula | C45H83N4O10PS |
| Synonyms: | 2-ammonioethyl ((R)-3-(oleoyloxy)-2-((12-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)dodecanoyl)oxy)propyl) phosphate |
| Shipping: | Free Shipping for worldwide on order above 2000 USD |
Product rating: 9 18:1-12:0 Biotin PE based on 20 ratings
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. Aripiprazole (1042634)
20. 2-(p-Tolyl)pyrimidine
This page contains information about 18:1-12:0 Biotin PE Cas 799812-67-2 and its Lipids.
18:1-12:0 Biotin PE 18:1-12:0 Biotin PE Worldwide Suppliers of 18:1-12:0 Biotin PE https://www.clearsynth.com/en/CSCC00179.html Lipids Clearsynth 799812-67-2
"Products currently covered by valid US Patents
are offered for R&D use in accordance with 35 USC 271(e)+A13(1).
Any patent infringement and resulting liability is solely at
buyer risk."